Pilgrim's Pride (PPC) Q2 2025 earnings summary

Executive summary

• Net sales for Q2 2025 reached $4.8 billion, up 4.3% year-over-year, with operating income of $512.3 million and net income of $356.0 million; adjusted EBITDA was $686.9 million (14.4% margin), driven by strong demand and operational efficiencies in the U.S. and Europe, while Mexico faced currency headwinds.

• Announced special dividends totaling $2.0 billion in 2025, including $1.5 billion in April and $500 million ($2.10/share) for September, alongside major investments such as a $400 million prepared foods plant in Georgia.

• Growth was supported by strong branded and prepared foods sales, portfolio diversification, and key customer outperformance.

• SG&A expenses declined year-over-year, mainly from reduced legal settlements and defense costs.

• Maintained strong liquidity and a net leverage ratio below 1.0x adjusted EBITDA at quarter-end.

Financial highlights

• Q2 2025 net sales were $4.76 billion, up 4.3% year-over-year; net income was $356.0 million ($1.49 per diluted share), and adjusted EBITDA was $686.9 million (14.4% margin).

• Gross profit for Q2 was $715.3 million (15.0% of net sales), and operating income was $512.3 million (10.8% margin).

• U.S. segment net sales were $2.82 billion, with adjusted operating income of $413.5 million and a 14.7% margin; Europe net sales were $1.37 billion with a 5.4% margin; Mexico net sales were $565.7 million with a 15.4% margin.

• Cash and cash equivalents at quarter-end were $849 million, with total assets of $10.1 billion.

• Adjusted net income per diluted share was $1.70, up from $1.67 in Q2 2024.

Outlook and guidance

• Continued investment in capacity expansion, especially in Mexico and U.S. prepared foods, with the new Georgia plant expected to increase U.S. prepared foods sales by over 40% from current levels.

• Management expects cash flows from operations and available credit to be sufficient for obligations, working capital, debt maturities, and capital spending for at least the next twelve months.

• USDA projects U.S. chicken production growth of 1.5% for 2025, matching strong demand; overall protein availability is expected to rise 1.3%.

• Full-year effective tax rate anticipated at 25%; net interest expense for 2025 guided to $115–$125 million.

• CapEx for 2025 expected at $650–$700 million, below the original $750 million estimate.